• Nenhum resultado encontrado

Sao Paulo Med. J. vol.129 número1

N/A
N/A
Protected

Academic year: 2018

Share "Sao Paulo Med. J. vol.129 número1"

Copied!
1
0
0

Texto

(1)

Sao Paulo Med J. 2011; 129(1):55-6

56

Cochr

ane highlights

Surgical excision margins for primary

cutaneous melanoma

Michael J. Sladden, Charles Balch, David A. Barzilai, Daniel

Berg, Anatoli Freiman, Teenah Handiside, Sally Hollis, Marko B.

Lens, John F. Thompson

“This is the abstract of a Cochrane Review published in the Cochrane Database of Systematic Reviews (CDSR) 2009, Issue 4, DOI: 10.1002/14651858.CD004835 (see www.thecochranelibrary.com for information). For full citation and authors details see reference 1.

The independent commentary is written by Francisco Aparecido Belfort.”

ABSTRACT

BACKGROUND: Cutaneous melanoma accounts for 75% of skin cancer deaths. Standard treatment is surgical excision with a safety margin some distance from the borders of the primary tumour. he purpose of the safety margin is to remove both the complete primary tumour and any melanoma cells that might have spread into the sur-rounding skin. Excision margins are important because there could be trade-of between a better cosmetic result but poorer long-term survival if margins become too narrow. he optimal width of excision margins remains unclear. his uncertainty warrants systematic review.

OBJECTIVES: To assess the efects of diferent excision margins for primary cutaneous melanoma.

SEARCH STRATEGY: In August 2009 we searched for relevant randomised trials in the Cochrane Skin Group Specialized Register; the Cochrane Central Register of Controlled Trials (CENTRAL) in he Cochrane Library (Issue 3, 2009), Medline, Embase, Lilacs, and other databases including Ongoing Trials Registers.

SELECTION CRITERIA: We considered all randomized con-trolled trials (RCTs) of surgical excision of melanoma comparing diferent width excision margins.

DATA COLLECTION AND ANALYSIS: We assessed trial qual-ity, and extracted and analyzed data on survival and recurrence. We collected adverse efects information from included trials.

MAIN RESULTS: We identiied ive trials. here were 1633 par-ticipants in the narrow excision margin group and 1664 in the wide excision margin group. Narrow margin deinition ranged from 1 to 2 cm; wide margins ranged from 3 to 5 cm. Median follow-up ranged from 5 to 16 years.

AUTHORS’ CONCLUSIONS: his systematic review summarises the evidence regarding width of excision margins for primary cutaneous melanoma. None of the ive published trials, nor our meta-analysis, showed a statistically signiicant diference in overall survival between narrow or wide excision. he summary estimate for overall survival favoured wide excision by a small degree [Hazard Ratio 1.04; 95% conidence interval 0.95 to 1.15; P = 0.40], but the result was not signiicantly diferent. his result is compatible with both a 5% relative reduction in overall mortality favouring narrower excision and a 15% relative reduction in overall mortality favouring wider excision. here-fore, a small (but potentially important) diference in overall survival between wide and narrow excision margins cannot be conidently ruled out. he summary estimate for recurrence free survival favoured wide excision [Hazard Ratio 1.13; P = 0.06; 95% conidence interval 0.99

to 1.28] but again the result did not reach statistical signiicance (P < 0.05 level). Current randomized trial evidence is insuicient to address optimal excision margins for primary cutaneous melanoma.

The review is fully available (through the Cochrane Journal Club) from:

http://www.cochranejournalclub.com/surgical-excision-margins-clinical/pdf/JC2_exci-sion_margins_full.pdf

REFERENCE

1. Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, Hollis S, Lens MB, Thomp-son JF. Surgical excision margins for primary cutaneous melanoma. Cochrane Database of Systematic Reviews 2009, Issue 4. Art. No.:CD004835. DOI: 10.1002/14651858. CD004835.pub2.

COMMENTS

his paper makes it clear that there is no proven statistically signiicant diference in overall survival or recurrence-free survival, between wide margins (3-5 cm) and narrow margins (1-2 cm) for treating cutaneous melanoma. At this moment, minimum margins of 1.0 cm and maximum margins of 2.0 cm are considered appropriate for speciic anatomical situations, without compromising the cure or quality of life of these patients. It has to be borne in mind that even though most studies in the literature only evaluated the prognostic factor of “thickness”, it is now well known that other prognostic factors such as sentinel node appearance, anatomical location and cytogenetic parameters need to be considered in proposals for future randomized studies aimed towards deining ideal margins.

Referências

Documentos relacionados

he current study demonstrates that the computerized formats of the Portuguese versions of the Multicultural Quality of Life Index and the Personal Health Scale are efective

hus, a systematic review of all randomized con- trolled trials identiied and selected from the search strategy that ad- dress the safety and efectiveness of treatment

Años o más) OR (Ancianos de 80 o más Años) OR (Ancianos de 80 Años o más) OR (Ancianos de 80 Años y más) OR (Idoso de 80 Anos ou mais ) OR Centenários OR Nonagenários

Perineuriomas are rare benign peripheral nerve sheath tumors arising mainly in the subcutis, but they have also been described in soft tissue and intraneural locations.. 11 hey

Associate professor, Department of Statistics, Universidade Federal de Juiz de Fora (UFJF), Juiz de Fora, Minas Gerais, Brazil. Attending physician, Department of Hematology,

hese trials covered many interventions, including acupressure, acustimulation, acupuncture, ginger, vitamin B6 and several antiemetic drugs.. We identiied no studies of dietary

Selection criteria: Randomized single or double-blind controlled trials enrolling women of reproductive age with a laparoscopically conirmed diagnosis of endometriosis and

Selection criteria: All randomized controlled trials (RCTs) of therapies re- lated to symptoms associated with primary or intrinsic tracheomalacia.. Data collection and analysis: